Non-opioid Pain Patch Market Analysis

  • Report ID: 5423
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Non-opioid Pain Patch Market Analysis

Product Type (Lidocaine Patch, Diclofenac Patch, Methyl Salicylate Patch, Capsaicin Patch, Ketoprofen Patch)

The lidocaine patch segment is estimated to account for 69% share of the global non-opioid pain patch market by 2037 owing to the growing incidence of chronic pain. An increasing number of people worldwide are affected by chronic pain, which can endure for months or years and disrupts day-to-day activities such as working, socializing, and taking care of others.

In order to lessen the intensity of all typical pain characteristics including arthritis, disk-related pain, and chronic lower back pain, and reduce opioid use in individuals, patch such as lidocaine patch can be used which are offered in both OTC and prescription strength formulations. According to estimates, in the US more than 6% of people experienced high-impact chronic pain in 2021.

Besides this, the capsaicin patch segment in the non-opioid pain patch market is anticipated to gain a noteworthy share in the coming years. Capsaicin is the component that gives chili peppers their heat and also what gives them their burning and irritating sensation. The pepper's seeds contain a significant amount of this unusual, organic compound and the hotter a pepper is, the more capsaicin it contains which acts as a pain reliever and the main component of pepper spray.

Qutenza, a high-dose capsaicin patch that has been licensed in recent years, to treat diabetic peripheral neuropathy (DPN) of the feet and to reduce the pain associated with postherpetic neuralgia.

Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

The online pharmacies segment in the non-opioid pain patch market is set to garner a notable share. The non-narcotic painkiller patch that are filled with painkilling medicine used for chronic painful disorders are easily accessible to the public through online pharmacies. Moreover, regardless of location, patients can acquire their pain patch from licensed pharmacists online, which not only makes purchasing more convenient nonetheless also benefits many consumers monetarily and is accompanied by a guarantee of the customer's safety and security.

Additionally, the non-opioid pain patch market from hospital Pharmacies, and retail pharmacies segment are poised to jointly hold notable shares during the forecast period. Retail pharmacies offer a large selection of prescription medications and over-the-counter pain patch to alleviate discomfort. Furthermore, hospital pharmacies frequently provide specialized services that improve patients' quality of life overall, working in tandem with doctors and other healthcare providers.

Our in-depth analysis of the global non-opioid pain patch market includes the following segments:

Product Type

  • Lidocaine Patch
  •  Diclofenac Patch
  • Methyl Salicylate Patch
  • Capsaicin Patch
  • Ketoprofen Patch

Distribution Channel

  • Hospital Pharmacies
  •  Retail Pharmacies
  •  Online Pharmacies
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5423
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of non-opioid pain patch is assessed at USD 3.73 billion.

The non-opioid pain patch market size was valued at USD 3.61 billion in 2024 and is likely to reach USD 6.16 billion by the end of 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037. Growing burden of diabetes across the globe and The growing development of advanced products will drive the market growth.

North America industry is likely to dominate majority revenue share 51% by 2037, impelled by presence of key players which has led to the development of new products in the region.

The major players in the market are GlaxoSmithKline Plc., Pfizer Inc., Hisamitsu Pharmaceutical Co., Inc., Clarion Brands, Endo Pharmaceuticals, TEH SENG Pharmaceutical, Teva Pharmaceutical Industries Ltd., Teikoku Seiyaku Co. Ltd., Veridian Healthcare, Sorrento Therapeutics (SCILEX Pharmaceuticals Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample